Welcome to LookChem.com Sign In|Join Free
  • or
lidocaine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

20846-29-1

Post Buying Request

20846-29-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20846-29-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 20846-29-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,8,4 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 20846-29:
(7*2)+(6*0)+(5*8)+(4*4)+(3*6)+(2*2)+(1*9)=101
101 % 10 = 1
So 20846-29-1 is a valid CAS Registry Number.

20846-29-1Downstream Products

20846-29-1Relevant academic research and scientific papers

IMPROVED PROCESS FOR THE SYNTHESIS OF 2, 6-XYLIDINE AND ITS DERIVATIVES

-

Paragraph 00042; 00044; 00045; 00056, (2017/06/12)

The disclosure herein provides a composition of compound of formula 1. The disclosure also provides a method of synthesizing the compound of formula 1 and its improved processes. The compound of formula 1 or its pharmaceutical acceptable salts, as well as polymorphs, solvates, and hydrates thereof may be formulated as pharmaceutical composition to be used for treatment of pain. The pharmaceutical composition of compound of formula 1 or the final compound may be formulated for noninvasive peroral, topical (example transdermal), enteral, transmucosal, targeted delivery, sustained release delivery, delayed release, pulsed release and parenteral methods. Such compositions may be used to treat chronic pain manifested with chronic diseases or its associated complications. The compound of formula 1 may also be offered as a kit.

2, 6 XYLIDINE DERIVATIVES FOR THE TREATMENT OF PAIN

-

Page/Page column 5, (2012/02/03)

The disclosure herein provides a composition compound of formula 1. The disclosure also provides a method of synthesizing the compound of formula 1. The compound of formula 1 or its pharmaceutical acceptable salts, as well as polymorphs, solvates, and hydrates thereof may be formulated as pharmaceutical composition to be used for treatment of pain. The pharmaceutical composition of compound of formula 1 or the final compound may be formulated for non-invasive peroral, topical (example transdermal), enteral, transmucosal, targeted delivery, sustained release delivery, delayed release, pulsed release and parenteral methods. Such compositions may be used to treat chronic pain manifested with chronic diseases or its associated complications. The compound of formula 1 may also be offered as a kit.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 20846-29-1